Marquette Asset Management »

Engene Therapeutics shares owned by Marquette Asset Management

Quarter-by-quarter ownership of Engene Therapeutics (ENGN) shares owned by Marquette Asset Management from 13F filings

Historical chart of Marquette Asset Management investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by Marquette Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by Marquette Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $260k 151k 1.73

More positions owned by Marquette Asset Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Rus 1000 Val Etf (IWD)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ishares Tr Rus 1000 Grw Etf (IWF)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Meta Platforms Cl A (META)
Dimensional Etf Trust Us Small Cap Etf (DFSV)

View all positions for Marquette Asset Management

Top funds holding Engene Therapeutics

Marshall Wace
Marquette Asset Management
SBI Securities

View all funds holding Engene Therapeutics